Search results for: 'computation fund dynamics cd'

Big pharma companies increasingly consider outsourcing manufacturing to CMOs as a strategic move because of the uncomplicated, timely, and cost-effective services CMOs provide as well as the fact that companes can then focus on their core competencies. This study provides market overview, market engineering measurements, revenue forecasts, competit...

This research service provides an in-depth analysis of the European refurbished medical imaging equipment market. It analyses the revenue potential, market dynamics, and trends across countries in Central and Eastern Europe and Western Europe as a combined European market. The revenue of the European refurbished medical imaging equipment market has...

Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...

08 Apr 2015  |  Asia Pacific  |  Market Research

Analysis of the TIM (Thailand, Indonesia, and Malaysia) Digital and Computed Radiography Markets

Technology Enhancements Accelerate Growth of X-ray Imaging

Infographics

×

This research service presents an analysis of the digital and computed radiography markets in Thailand, Malaysia, and Indonesia (TIM). It provides an in-depth analysis of the current trends and market size, as well as regional market drivers and restraints. The study offers revenue forecasts by country and discusses market penetration and market at...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...

This report examines the regulations surrounding digital health in North America and Europe. It provides a general analysis of key national and regional regulatory updates that will impact digital health players and influence market dynamics. The regulatory documents considered are those governing the healthcare sector and applicable to digital hea...

This research service provides critical insights into the impact of COVID-19 on the global in-vitro diagnostics (IVD) industry, highlighting the growth opportunities, market revenue, and technology trends that influence its growth. Its three major segments identify the strategic imperatives of the IVD industry, the impact of COVID-19 on the IVD gro...

Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...